Search results: Sage Journals

Open accessCase reportFirst published 2022

Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy

Kamilya A. Schumacher, Aidar R. Gosmanov

Journal of Investigative Medicine High Impact Case Reports

Free accessResearch articleFirst published July, 2014

The Role of Self-Monitoring of Blood Glucose in Patients Treated With SGLT-2 Inhibitors

Oliver Schnell, Hasan Alawi, Tadej Battelino [...]

Journal of Diabetes Science and Technology

Open accessReview articleFirst published 2024

Role of SGLT-2 Inhibitors in Ultrafiltration Failure in Peritoneal Dialysis: A Narrative Review

Magdalena Riedl Khursigara, Ping Liu, Reetinder Kaur [...]

Canadian Journal of Kidney Health and Disease

Restricted accessReview articleFirst published September, 2017

SGLT-2 Inhibitors: Is There a Role in Type 1 Diabetes Mellitus Management?

Nabila Ahmed-Sarwar, Angela K. Nagel, Samantha Leistman [...]

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published April, 2024

Comparison of A1c Reduction,Weight Loss,and Changes in Insulin Requirements With Addition of GLP-1 Agonists vs SGLT-2 Inhibitors in Patients Using Multiple Daily Insulin Injections

Gunther Wehrman, Micah Halton, Brynn Riveland [...]

Journal of Pharmacy Practice

Restricted accessCase reportFirst published January, 2020

Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and “Sweet Pee Encephalopathy” in Perioperative Hospital Management

Christopher Mackintosh, Arti Tewari, Jason Siegel [...]

The Neurohospitalist

Open accessCase reportFirst published 2022

The Use of SGLT-2 Inhibitors Coupled With a Strict Low-Carbohydrate Diet: A Set-Up for Inducing Severe Diabetic Ketoacidosis

Helpees Guirguis, Shiela Beroukhim Afrahimi, Charles Pham

Clinical Medicine Insights: Case Reports

Restricted accessReview articleFirst published September, 2015

The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure

Kayla Riggs, Hiba Ali, Heinrich Taegtmeyer [...]

Metabolic Syndrome and Related Disorders

Restricted accessCase reportFirst published June, 2026

Use of SGLT 2 inhibition in the management of hyponatremia in a patient with metastatic cancer

Eilis Eschweiler, Anna Gaddy, Paul E. Hanna

Journal of Onco-Nephrology

Open accessResearch articleFirst published 2019

Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus

Lea El Hage, Sangeeta R Kashyap, Pratibha Rao

Journal of Primary Care & Community Health

Open accessCase reportFirst published 2022

Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy

Kamilya A. Schumacher, Aidar R. Gosmanov

Journal of Investigative Medicine High Impact Case Reports

Free accessResearch articleFirst published July, 2014

The Role of Self-Monitoring of Blood Glucose in Patients Treated With SGLT-2 Inhibitors

Oliver Schnell, Hasan Alawi, Tadej Battelino [...]

Journal of Diabetes Science and Technology

Open accessReview articleFirst published 2024

Role of SGLT-2 Inhibitors in Ultrafiltration Failure in Peritoneal Dialysis: A Narrative Review

Magdalena Riedl Khursigara, Ping Liu, Reetinder Kaur [...]

Canadian Journal of Kidney Health and Disease

Restricted accessReview articleFirst published September, 2017

SGLT-2 Inhibitors: Is There a Role in Type 1 Diabetes Mellitus Management?

Nabila Ahmed-Sarwar, Angela K. Nagel, Samantha Leistman [...]

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published April, 2024

Comparison of A1c Reduction,Weight Loss,and Changes in Insulin Requirements With Addition of GLP-1 Agonists vs SGLT-2 Inhibitors in Patients Using Multiple Daily Insulin Injections

Gunther Wehrman, Micah Halton, Brynn Riveland [...]

Journal of Pharmacy Practice

Restricted accessCase reportFirst published January, 2020

Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and “Sweet Pee Encephalopathy” in Perioperative Hospital Management

Christopher Mackintosh, Arti Tewari, Jason Siegel [...]

The Neurohospitalist

Open accessCase reportFirst published 2022

The Use of SGLT-2 Inhibitors Coupled With a Strict Low-Carbohydrate Diet: A Set-Up for Inducing Severe Diabetic Ketoacidosis

Helpees Guirguis, Shiela Beroukhim Afrahimi, Charles Pham

Clinical Medicine Insights: Case Reports

Restricted accessReview articleFirst published September, 2015

The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure

Kayla Riggs, Hiba Ali, Heinrich Taegtmeyer [...]

Metabolic Syndrome and Related Disorders

Restricted accessCase reportFirst published June, 2026

Use of SGLT 2 inhibition in the management of hyponatremia in a patient with metastatic cancer

Eilis Eschweiler, Anna Gaddy, Paul E. Hanna

Journal of Onco-Nephrology

Open accessResearch articleFirst published 2019

Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus

Lea El Hage, Sangeeta R Kashyap, Pratibha Rao

Journal of Primary Care & Community Health